Literature DB >> 16511759

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers.

Catherine Cordonnier1, Patricia Ribaud, Raoul Herbrecht, Noël Milpied, Dominique Valteau-Couanet, Caroline Morgan, Amath Wade.   

Abstract

BACKGROUND: Invasive aspergillosis (IA) is a major cause of death after hematopoietic stem cell transplantation (HSCT). The goal of this retrospective and consecutive survey was to assess prognostic factors of death due to IA after HSCT at the time of diagnosis of IA.
METHODS: All 64 health care centers affiliated with the Société Française de Greffe de Moelle et de Thérapie Cellulaire were contacted to participate in this study of all proven or probable cases of IA that occurred among HSCT recipients in 2002. Data for 51 cases (41 involving allogeneic HSCT and 10 involving autologous HSCT) were collected from patient records and included diagnostic and therapeutic features of IA, outcome, presence of hematological disease, and transplantation data. Cox models were applied to risk factors for death attributed to IA that were initially identified using the usual tests.
RESULTS: The proportion of deaths attributed to IA within 4 months after diagnosis was 0.62 (95% confidence interval, 0.47-0.76). Seven factors assessed at diagnosis were determined to be strongly related to death due to IA: age of 12-35 years, dissemination of IA, presence of a pleural effusion, monocyte count of <120 cells/mm3, prolonged administration of steroids within the previous 2 months, receipt of a dose > or =2 mg/kg at the time of diagnosis, and uncontrolled graft-versus-host disease.Conclusions. Our study explored potential risk factors for death due to IA among HSCT recipients as a reference for investigation in larger future studies. These factors should help to identify HSCT recipients who would benefit from more-aggressive antifungal therapies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16511759     DOI: 10.1086/500934

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  34 in total

1.  Factors associated with mortality in transplant patients with invasive aspergillosis.

Authors:  John W Baddley; David R Andes; Kieren A Marr; Dimitrios P Kontoyiannis; Barbara D Alexander; Carol A Kauffman; Robert A Oster; Elias J Anaissie; Thomas J Walsh; Mindy G Schuster; John R Wingard; Thomas F Patterson; James I Ito; O Dale Williams; Tom Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-06-15       Impact factor: 9.079

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Authors:  Jutta Auberger; Cornelia Lass-Flörl; Hanno Ulmer; Elisabeth Nogler-Semenitz; Johannes Clausen; Eberhard Gunsilius; Hermann Einsele; Günther Gastl; David Nachbaur
Journal:  Int J Hematol       Date:  2008-11-05       Impact factor: 2.490

4.  Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge.

Authors:  Shinji Kasahara; Anupam Jhingran; Sourabh Dhingra; Anand Salem; Robert A Cramer; Tobias M Hohl
Journal:  J Infect Dis       Date:  2016-02-09       Impact factor: 5.226

5.  Epidemiology, outcomes, and mortality predictors of invasive mold infections among transplant recipients: a 10-year, single-center experience.

Authors:  D Neofytos; S Treadway; D Ostrander; C D Alonso; K L Dierberg; V Nussenblatt; C M Durand; C B Thompson; K A Marr
Journal:  Transpl Infect Dis       Date:  2013-02-21       Impact factor: 2.228

6.  Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.

Authors:  Simone Aranha Nouér; Marcio Nucci; Naveen Sanath Kumar; Monica Grazziutti; Alejandro Restrepo; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

7.  Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis.

Authors:  Géraldine Salmeron; Raphaël Porcher; Anne Bergeron; Marie Robin; Régis Peffault de Latour; Christèle Ferry; Vanderson Rocha; Anna Petropoulou; Aliénor Xhaard; Claire Lacroix; Annie Sulahian; Gérard Socié; Patricia Ribaud
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

8.  Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles.

Authors:  Elizabeth R Ramos; Ying Jiang; Ray Hachem; Christelle Kassis; Dimitrios P Kontoyiannis; Issam Raad
Journal:  Oncologist       Date:  2011-06-09

9.  Idiopathic pneumonia syndrome after hematopoietic cell transplantation: evidence of occult infectious etiologies.

Authors:  Sachiko Seo; Christian Renaud; Jane M Kuypers; Charles Y Chiu; Meei-Li Huang; Erik Samayoa; Hu Xie; Guixia Yu; Cynthia E Fisher; Ted A Gooley; Steven Miller; Robert C Hackman; David Myerson; Ruth H Sedlak; Yae-Jean Kim; Takahiro Fukuda; David N Fredricks; David K Madtes; Keith R Jerome; Michael Boeckh
Journal:  Blood       Date:  2015-04-27       Impact factor: 22.113

10.  Distinct responses of human monocyte subsets to Aspergillus fumigatus conidia.

Authors:  Natalya V Serbina; Mathew Cherny; Chao Shi; Sharon A Bleau; Nancy H Collins; James W Young; Eric G Pamer
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.